查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2080386

麻醉劑市場：2026-2032年全球市場預測（依藥物類型、給藥途徑、作用持續時間、應用、最終用戶和分銷管道分類）

Anesthetic Drugs Market by Drug Type, Administration Route, Duration of Action, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，麻醉劑市場規模將成長至 137.8 億美元，複合年成長率為 5.92%。

主要市場統計數據
基準年 2025 92.1億美元
預計年份：2026年 97.4億美元
預測年份 2032 137.8億美元
複合年成長率 (%) 5.92%

麻醉劑市場概覽

麻醉劑市場透過提供安全的麻醉誘導、維持、局部麻醉、術中鎮靜和手術全期手術期疼痛管理，為現代外科手術、急診醫學、產科、牙科、重症監護和疼痛管理提供支援。市場需求成長的促進因素包括外科手術量的增加、人口老化、創傷治療需求、慢性疾病負擔的加重以及門診手術設施的擴張。

一項將重塑麻醉實踐的變革性變革。

麻醉劑的發展趨勢正從以醫院為中心的麻醉模式轉向針對特定治療的模式、加速復健的模式以及門診護理模式。在日間手術中心和短期住院治療單元，對短效藥物、可預測的康復、減少術後噁心嘔吐以及高效的出院流程的需求日益成長。

人工智慧對麻醉劑的累積影響

人工智慧正透過臨床決策支援工具、預測性監測、自動記錄和分析功能，影響麻醉劑的使用，從而識別低血壓、呼吸抑制、術後噁心和延遲甦醒等風險。這些應用與檢驗的臨床工作流程和持續生理監測相結合，可以支持早期介入。

關於麻醉劑的關鍵區域見解

北美憑藉其先進的外科基礎設施、大規模的門診手術網路、完善的醫院藥房系統以及品牌和非專利注射麻醉劑的廣泛供應，仍然是麻醉劑的高價值地區。歐洲的優勢包括全民健保、成熟的報銷體系、完善的麻醉培訓以及對揮發性麻醉劑選擇的重新評估（重點關注永續性） ，同時區域監管協調也支持跨境商業化和藥物安全監測的一致性。

針對東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵群體特定見解

在東協地區，醫療保健投資的增加、醫療旅遊的擴張以及私人醫院的發展，推動了手術和操作過程中對注射劑、吸入劑和局部麻醉劑的需求。海灣合作理事會（GCC）市場則受益於專科醫院的發展、高昂的手術相關支出、政府主導的醫療保健改革計劃以及三級醫療機構對先進圍手術全期護理的需求。

針對主要麻醉劑市場的關鍵國別洞察

美國在手術量、門診手術普及率、麻醉創新、無菌注射劑使用以及手術全期位化整合方面主導，而加拿大則專注於循證醫學、處方藥清單管理以及以安全為導向的醫院採購。墨西哥和巴西正透過發展私立醫院、公共部門採購以及增加外科手術服務來擴大麻醉劑的可近性。

為行業領導者提供的實用建議

產業領導者應優先考慮差異化配方、可靠的無菌生產以及涵蓋全身麻醉劑、局部麻醉劑、鎮靜劑、鎮痛輔助劑和神經肌肉阻斷劑類別的廣泛產品系列。供不應求麻醉劑短缺會導致手術延誤、急救服務中斷以及醫院手術室效率下降。

麻醉劑調查方法

對麻醉劑進行全面評估需要結合監管機構的二次調查、科學文獻、醫院採購資訊來源、基本藥物清單、臨床指南、短缺資料庫、產品標籤、藥物安全監測記錄和公共衛生資訊來源。初步檢驗應包括麻醉醫師、醫院藥劑師、採購經理、批發商、無菌生產專家和監管專家。

結論：麻醉劑的策略展望

隨著外科手術、介入治療、急診醫學、產科、牙科、重症監護和疼痛管理在全球範圍內的擴展，麻醉劑仍將是醫療保健系統不可或缺的一部分。在醫院容量、門診手術、保險報銷、藥品供應以及合格麻醉醫師的培訓同步發展的地區，這一趨勢尤其顯著。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：麻醉劑市場：依藥物類型分類

  • 全身麻醉劑
  • 局部麻醉劑
    • 醯胺型
    • 酯類

第8章：麻醉劑市場：依給藥途徑分類

  • 吸入
  • 肌肉內部
  • 靜脈

第9章：麻醉劑市場：依作用持續時間分類

  • 長效型
  • 短效

第10章：麻醉劑市場：依應用領域分類

  • 牙科手術
    • 外科手術
    • 預防
  • 產科
  • 疼痛管理
    • 急性疼痛
    • 慢性疼痛
  • 外科手術
    • 心臟外科手術
    • 一般外科
    • 神經外科
    • 整形外科手術
    • 整形外科

第11章：麻醉劑市場：依最終用戶分類

  • 門診手術中心
  • 醫院和診所

第12章：麻醉劑市場：依通路分類

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第13章：麻醉劑市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章：麻醉劑市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：麻醉劑市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Abbott Laboratories
  • AbbVie Inc.
  • Amneal Pharmaceuticals LLC
  • Apotex Inc.
  • Aspen Pharmacare Holdings Limited
  • AstraZeneca PLC
  • B. Braun SE
  • Baxter International Inc.
  • Boehringer Ingelheim International GmbH
  • Claris Lifesciences Limited
  • Dr. Reddy's Laboratories Limited
  • Eisai Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Fresenius SE & Co. KGaA
  • Hikma Pharmaceuticals PLC
  • Lupin Limited
  • Mallinckrodt Pharmaceuticals plc
  • Novartis AG
  • Pacira Pharmaceuticals, Inc.
  • PAION AG
  • Pfizer Inc.
  • Piramal Enterprises LTD
  • Septodont Healthcare India Pvt. Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Limited
  • Viatris Inc.
  • Weefsel Pharma
Product Code: MRR-434CCDA05121

The Anesthetic Drugs Market is projected to grow by USD 13.78 billion at a CAGR of 5.92% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 9.21 billion
Estimated Year [2026] USD 9.74 billion
Forecast Year [2032] USD 13.78 billion
CAGR (%) 5.92%

Anesthetic Drugs Market Executive Overview

The anesthetic drugs market underpins modern surgery, emergency care, obstetrics, dentistry, intensive care, and pain management by enabling safe induction, maintenance, regional blockade, procedural sedation, and perioperative pain control. Demand is supported by rising surgical volumes, aging populations, trauma care needs, growing chronic disease burden, and expanding ambulatory surgery capacity.

Clinically established agents such as propofol, sevoflurane, desflurane, isoflurane, ketamine, lidocaine, bupivacaine, ropivacaine, midazolam, dexmedetomidine, and neuromuscular adjuncts remain central to perioperative protocols. Competitiveness increasingly depends on safety profiles, onset and recovery characteristics, reduced postoperative complications, supply reliability, pharmacoeconomic value, and compliance with controlled-substance, sterile manufacturing, and pharmacovigilance requirements.

Transformative Shifts Reshaping Anesthesia Practice

The anesthetic drugs landscape is shifting from hospital-centric anesthesia toward procedure-specific, enhanced-recovery, and outpatient care models. Ambulatory surgery centers and short-stay procedural units are increasing the need for short-acting agents, predictable recovery, low postoperative nausea and vomiting, and efficient discharge pathways.

At the same time, sustainability concerns are reshaping inhaled anesthetic use because volatile agents differ in atmospheric persistence and greenhouse gas potential. Procurement teams are prioritizing resilient sourcing following documented global medicine shortages, while clinicians continue to adopt multimodal analgesia and regional anesthesia techniques to reduce opioid exposure and improve recovery outcomes.

Cumulative Impact of Artificial Intelligence on Anesthetic Drugs

Artificial intelligence is influencing anesthetic drug use through clinical decision-support tools, predictive monitoring, automated documentation, and analytics that identify risks such as hypotension, respiratory depression, postoperative nausea, and delayed emergence. These applications can support earlier intervention when integrated with validated clinical workflows and continuous physiologic monitoring.

AI also strengthens demand planning, inventory management, pharmacovigilance signal detection, shortage mitigation, and clinical trial design for anesthetic drugs. However, adoption requires transparent algorithms, cybersecurity safeguards, human oversight, bias monitoring, and alignment with FDA, EMA, and local medical-device software expectations.

Key Regional Insights for Anesthetic Drugs

North America remains a high-value region for anesthetic drugs due to advanced surgical infrastructure, large ambulatory surgery networks, robust hospital pharmacy systems, and strong uptake of branded and generic injectable anesthetics. Europe benefits from universal-care systems, mature reimbursement, established anesthesia training, and sustainability-led review of volatile anesthetic choices, while regional regulatory harmonization supports cross-border commercialization and pharmacovigilance consistency.

Asia-Pacific is expanding as China, India, Japan, South Korea, Australia, and ASEAN countries invest in hospitals, day-care surgery, operating-room modernization, and anesthesia workforce development. Latin America, led by Brazil and Mexico, shows improving procedure access through public procurement and private hospital expansion, whereas the Middle East presents growth tied to specialty hospital investment, medical tourism, and healthcare modernization. Africa remains focused on essential-medicine access, perioperative safety, anesthesia workforce availability, and supply-chain strengthening across public health systems.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

Within ASEAN, rising healthcare investment, medical tourism, and private hospital development are increasing demand for injectable, inhaled, and local anesthetics across surgical and procedural settings. GCC markets are supported by specialty hospital development, high surgical spending, government-backed healthcare transformation programs, and demand for advanced perioperative care in tertiary facilities.

The European Union emphasizes quality standards, pharmacovigilance, environmental stewardship, and procurement efficiency for anesthetic drugs. BRICS countries combine large patient bases with expanding hospital infrastructure and domestic manufacturing ambitions, while G7 markets lead in clinical standards, digital anesthesia integration, sterile injectable quality systems, and premium formulations. NATO-aligned healthcare systems also prioritize resilient medical supply chains for civilian preparedness, defense readiness, and continuity of essential surgical services.

Key Country Insights in Leading Anesthetic Drug Markets

The United States leads in procedure volume, ambulatory surgery adoption, anesthesia innovation, sterile injectable utilization, and perioperative digital integration, while Canada emphasizes evidence-based care, formulary stewardship, and safety-focused hospital procurement. Mexico and Brazil are scaling access to anesthetic drugs through private hospital expansion, public-sector purchasing, and growing surgical service availability.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain mature anesthesia demand supported by established hospital networks, trained anesthesia professionals, and standardized perioperative protocols, while Russia retains significant domestic hospital needs and supply localization priorities. China and India are high-growth anesthetic drug markets due to surgical capacity expansion, hospital investment, and broader access to procedural care; Japan, South Korea, and Australia emphasize advanced monitoring, safety protocols, high-quality perioperative care, and adoption of evidence-based anesthesia practices.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize differentiated formulations, dependable sterile manufacturing, and portfolio breadth across general anesthetics, local anesthetics, sedatives, analgesic adjuncts, and neuromuscular support categories. Supply security is essential because anesthetic drug shortages can delay surgery, disrupt emergency care, and compromise hospital operating-room efficiency.

Organizations should invest in real-world evidence, sustainability data for inhaled agents, AI-enabled demand planning, and education that supports safe dosing, storage, administration, and adverse-event reporting. Partnerships with hospitals, pharmacists, anesthesiology societies, and ambulatory surgery centers can improve clinical relevance, strengthen formulary access, and support safer perioperative outcomes.

Research Methodology for Anesthetic Drugs Intelligence

A robust anesthetic drugs assessment should combine secondary research from regulatory agencies, scientific literature, hospital procurement sources, essential-medicine lists, clinical guidelines, shortage databases, product labeling, pharmacovigilance records, and public health sources. Primary validation should include anesthesiologists, hospital pharmacists, procurement directors, distributors, sterile manufacturing experts, and regulatory specialists.

Segmentation should evaluate drug class, route of administration, formulation, application, end user, regulatory status, and geography without relying on unsupported assumptions. Triangulation across procedure trends, pricing signals, import-export patterns, product approvals, shortages, clinical standards, and competitive portfolios improves reliability and supports executive-level decision-making.

Conclusion: Strategic Outlook for Anesthetic Drugs

Anesthetic drugs will remain indispensable to healthcare systems as surgical care, interventional procedures, emergency medicine, obstetrics, dentistry, intensive care, and pain management expand worldwide. Momentum is strongest where hospital capacity, ambulatory surgery, reimbursement, medicine availability, and trained anesthesia professionals advance together.

Successful organizations will combine clinical safety, manufacturing resilience, cost-effectiveness, regulatory discipline, sustainability awareness, and digital readiness. As AI, environmental stewardship, and value-based procurement reshape anesthetic drug decisions, organizations that align innovation with measurable patient and operational outcomes will be best positioned.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Anesthetic Drugs Market, by Drug Type

  • 7.1. General Anesthetics
  • 7.2. Local Anesthetics
    • 7.2.1. Amides
    • 7.2.2. Esters

8. Anesthetic Drugs Market, by Administration Route

  • 8.1. Inhalation
  • 8.2. Intramuscular
  • 8.3. Intravenous

9. Anesthetic Drugs Market, by Duration of Action

  • 9.1. Long-Acting
  • 9.2. Short-Acting

10. Anesthetic Drugs Market, by Application

  • 10.1. Dental Procedures
    • 10.1.1. Operative
    • 10.1.2. Preventive
  • 10.2. Obstetrics
  • 10.3. Pain Management
    • 10.3.1. Acute Pain
    • 10.3.2. Chronic Pain
  • 10.4. Surgical Procedures
    • 10.4.1. Cardiac Surgery
    • 10.4.2. General Surgery
    • 10.4.3. Neuro Surgery
    • 10.4.4. Orthopedic Surgery
    • 10.4.5. Plastic Surgery

11. Anesthetic Drugs Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals & Clinics

12. Anesthetic Drugs Market, by Distribution Channel

  • 12.1. Hospital Pharmacies
  • 12.2. Retail Pharmacies
  • 12.3. Online Pharmacies

13. Anesthetic Drugs Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Anesthetic Drugs Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Anesthetic Drugs Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Abbott Laboratories
  • 17.2. AbbVie Inc.
  • 17.3. Amneal Pharmaceuticals LLC
  • 17.4. Apotex Inc.
  • 17.5. Aspen Pharmacare Holdings Limited
  • 17.6. AstraZeneca PLC
  • 17.7. B. Braun SE
  • 17.8. Baxter International Inc.
  • 17.9. Boehringer Ingelheim International GmbH
  • 17.10. Claris Lifesciences Limited
  • 17.11. Dr. Reddy's Laboratories Limited
  • 17.12. Eisai Co. Ltd.
  • 17.13. F. Hoffmann-La Roche Ltd.
  • 17.14. Fresenius SE & Co. KGaA
  • 17.15. Hikma Pharmaceuticals PLC
  • 17.16. Lupin Limited
  • 17.17. Mallinckrodt Pharmaceuticals plc
  • 17.18. Novartis AG
  • 17.19. Pacira Pharmaceuticals, Inc.
  • 17.20. PAION AG
  • 17.21. Pfizer Inc.
  • 17.22. Piramal Enterprises LTD
  • 17.23. Septodont Healthcare India Pvt. Ltd.
  • 17.24. Sun Pharmaceutical Industries Ltd.
  • 17.25. Teva Pharmaceutical Industries Limited
  • 17.26. Viatris Inc.
  • 17.27. Weefsel Pharma

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANESTHETIC DRUGS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ANESTHETIC DRUGS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ANESTHETIC DRUGS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ANESTHETIC DRUGS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANESTHETIC DRUGS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL ANESTHETIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GENERAL ANESTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GENERAL ANESTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GENERAL ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LOCAL ANESTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LOCAL ANESTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LOCAL ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AMIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AMIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AMIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ESTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ESTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ESTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INHALATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INHALATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INHALATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAMUSCULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTRAMUSCULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAMUSCULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTRAVENOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAVENOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INTRAVENOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL LONG-ACTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL LONG-ACTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LONG-ACTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SHORT-ACTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SHORT-ACTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SHORT-ACTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DENTAL PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DENTAL PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DENTAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL OPERATIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL OPERATIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL OPERATIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PREVENTIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PREVENTIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PREVENTIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL OBSTETRICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL OBSTETRICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL OBSTETRICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ACUTE PAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ACUTE PAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ACUTE PAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CHRONIC PAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CHRONIC PAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CHRONIC PAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CARDIAC SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CARDIAC SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CARDIAC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GENERAL SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GENERAL SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GENERAL SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEURO SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NEURO SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEURO SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PLASTIC SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PLASTIC SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PLASTIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. GCC ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 169. GCC ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. GCC ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 171. GCC ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 172. GCC ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 173. GCC ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. GCC ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 175. GCC ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 176. GCC ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 177. GCC ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. GCC ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. G7 ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. G7 ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. G7 ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 204. G7 ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 205. G7 ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 206. G7 ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. G7 ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 208. G7 ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 209. G7 ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 210. G7 ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. G7 ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 212. NATO ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 213. NATO ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. NATO ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 215. NATO ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 216. NATO ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 217. NATO ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. NATO ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 219. NATO ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 220. NATO ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 221. NATO ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. NATO ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 235. CANADA ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. CANADA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. CANADA ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 238. CANADA ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 239. CANADA ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 240. CANADA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. CANADA ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 242. CANADA ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 243. CANADA ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 244. CANADA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. CANADA ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. MEXICO ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 249. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 250. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 251. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 253. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 254. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 255. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 257. BRAZIL ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 258. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 260. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 261. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 262. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 264. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 265. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 266. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED KINGDOM ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 279. GERMANY ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 280. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 282. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 283. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 284. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 285. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 286. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 287. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 288. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 289. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 290. FRANCE ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 291. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 293. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 294. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 295. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 296. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 297. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 298. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 299. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 301. RUSSIA ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 302. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 304. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 305. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 306. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 307. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 308. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 309. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 310. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 311. RUSSIA ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 312. ITALY ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 313. ITALY ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. ITALY ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 315. ITALY ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 316. ITALY ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 317. ITALY ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 318. ITALY ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 319. ITALY ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 320. ITALY ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 321. ITALY ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 322. ITALY ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 323. SPAIN ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 324. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 325. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 326. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 327. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 328. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 329. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 330. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 331. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 332. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 333. SPAIN ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 334. CHINA ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 335. CHINA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 336. CHINA ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 337. CHINA ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 338. CHINA ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 339. CHINA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 340. CHINA ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 341. CHINA ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 342. CHINA ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 343. CHINA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 344. CHINA ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 345. INDIA ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 346. INDIA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 347. INDIA ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 348. INDIA ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 349. INDIA ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 350. INDIA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 351. INDIA ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 352. INDIA ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 353. INDIA ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 354. INDIA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 355. INDIA ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 356. JAPAN ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 357. JAPAN ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 358. JAPAN ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 359. JAPAN ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 360. JAPAN ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 361. JAPAN ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 362. JAPAN ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 363. JAPAN ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 364. JAPAN ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 365. JAPAN ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 366. JAPAN ANESTHETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 367. AUSTRALIA ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 368. AUSTRALIA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABL